Free shipping on all orders over $ 500

GSK3494245

Cat. No. M29173
GSK3494245 Structure
Synonym:

DDD01305143​

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK3494245 (DDD01305143) is a potent, orally active, and selective inhibitor of the chymotrypsin-like activity of the parasite proteasome binding in a site sandwiched between the β4 and β5 subunits (IC50=0.16 μM for WT L. donovani proteasomes). GSK3494245 moderately inhibits chymotrypsin-like activity of human proteasome (IC50: purified 26S=13 µM; enriched THP-1 extracts IC50=40µM). GSK3494245 exhibits attractive biological and biosafety properties.

Chemical Information
Molecular Weight 410.44
Formula C21H23FN6O2
CAS Number 2080410-41-7
Form Solid
Solubility (25°C) DMSO 100 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Mohd Imran, et al. Expert Opin Ther Pat. Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021

[2] Michael Thomas, et al. J Med Chem. Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

[3] Susan Wyllie, et al. Proc Natl Acad Sci U S A. Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Related Parasite Products
Argifin

Argifin is a sub-nanomolar chitinase inhibitor produced by soil microorganisms.

Argadin

Argadin is a cyclopentapeptide chitinase inhibitor.

DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS

DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS is a fluorescent dye, and can be applied in a fluorogenic substrate for an aspartyl proteinase from human malaria parasite.

Xenopsin precursor fragment

Xenopsin precursor fragment is an antimicrobial peptide, and has antibacterial/antifungal (10-500 μg/mL) and anti-protozoal (MIC: 2-20 μg/mL) activity.

Dihydrocyclosporin A

Dihydrocyclosporin A is a derivative of Cyclosporine A.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK3494245, DDD01305143​ supplier, Parasite, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.